Esophageal cancer: What price swallowing?

Journal of the American College of Surgeons

Volumn 196, Issue 3, 2003, Pages 347-353

  Wong, John ^a   Law, Simon ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; DYSPHAGIA; ESOPHAGUS CARCINOMA; HUMAN; PALLIATIVE THERAPY; PEROPERATIVE CARE; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SURGICAL MORTALITY; TREATMENT PLANNING;

EID: 0037345648     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(02)01807-0     Document Type: Review

References (52)

1. Bown SG. Palliation of malignant dysphagia: surgery, radiotherapy, laser, intubation alone or in combination? Gut 1991;32:841-844.
2. Loizou LA, Rampton D, Atkinson M, et al. A prospective assessment of quality of life after endoscopic intubation and laser therapy for malignant dysphagia. Cancer 1992;70:386-391.
3. Nicholson DA, Haycox A, Kay CL, et al. The cost effectiveness of metal oesophageal stenting in malignant disease compared with conventional therapy. Clin Radiol 1999;54:212-215.
4. O'Rourke IC, McNeil RJ, Walker PJ, Bull CA. Objective evaluation of the quality of palliation in patients with oesophageal cancer comparing surgery, radiotherapy and intubation. Aust N Z J Surg 1992;62:922-930.
5. O'Rourke IC, Tiver K, Bull C, et al. Swallowing performance after radiation therapy for carcinoma of the esophagus. Cancer 1988;61:2022-2026.
6. Badwe RA, Sharma V, Bhansali MS, et al. The quality of swallowing for patients with operable esophageal carcinoma: a randomized trial comparing surgery with radiotherapy. Cancer 1999;85:763-768.
7. Jamieson GG, Mathew G. Surgical management of esophageal cancer: the Western experience. In: Daly JM, Hennessy TPJ, Reynolds JV, eds. Management of upper gastrointestinal cancer. London: WB Saunders; 1999:183-199.
8. Muller JM, Erasmi H, Stelzner M, et al. Surgical therapy of oesophageal carcinoma. Br J Surg 1990;77:845-857.
9. Medical Research Council Oesophageal Cancer Working Party. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002;359:1727-1733.
10. Hulscher JB, Tijssen JG, Obertop H, van Lanschot JJ. Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis. Ann Thorac Surg 2001;72:306-313.
11. Whooley BP, Law S, Murthy SC, et al. Analysis of reduced death and complication rates after esophageal resection. Ann Surg 2001;233:338-344.
12. Siewert JR, Feith M, Werner M, Stein HJ. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg 2000;232:353-361.
13. Ando N, Ozawa S, Kitagawa Y, et al. Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 2000;232:225-232.
14. Swisher SG, Deford L, Merriman KW, et al. Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg 2000;119:1126-1132.
15. Begg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery. JAMA 1998;280:1747-1751.
16. Patti MG, Costantini M, Godwin DH, Way LW. A hospital's annual rate of esophagectomy influences the operative mortality rates. J Gastrointest Surg 1998;2:186-192.
17. Law S, Fok M, Chu KM, Wong J. Comparison of hand-sewn and stapled esophagogastric anastomosis after esophageal resection for cancer: a prospective randomized controlled trial. Ann Surg 1997;226:169-173.
18. Whooley BP, Law S, Alexandrou A, et al. Critical appraisal of the significance of intrathoracic anastomotic leakage after esophagectomy for cancer. Am J Surg 2001;181:198-203.
19. Law SY, Fok M, Wong J. Risk analysis in resection of squamous cell carcinoma of the esophagus. World J Surg 1994;18:339-346.
20. Urschel JD. Esophagogastrostomy anastomotic leaks complicating esophagectomy: a review. Am J Surg 1995;169:634-640.
21. Lerut T, Coosemans W, Decker G, et al. Anastomotic complications after esophagectomy. Dig Surg 2002;19:92-98.
22. Wong J, Cheung HC, Lui R, et al. Esophagogastric anastomosis performed with a stapler: the occurrence of leakage and stricture. Surgery 1987;101:408-415.
23. Orringer MB, Marshall B, Iannettoni MD. Eliminating the cervical esophagogastric anastomotic leak with a side-to-side stapled anastomosis. J Thorac Cardiovasc Surg 2000;119:277-288.
24. Moorehead RJ, Wong J. Gangrene in esophageal substitutes after resection and bypass procedures for carcinoma of the esophagus. Hepatogastroenterology 1990;37:364-367.
25. Murthy S, Law S, Whooley BP, et al. Atrial fibrillation after esophagectomy is a marker for pulmonary, septic complications, and poor outcome. Unpublished data, 2002.
26. Law S, Arcilla C, Chu KM, Wong J. The significance of histologically infiltrated resection margin after esophagectomy for esophageal cancer. Am J Surg 1998;176:286-290.
27. Law SY, Fok M, Cheng SW, Wong J. A comparison of outcome after resection for squamous cell carcinomas and adenocarcinomas of the esophagus and cardia. Surg Gynecol Obstet 1992;175:107-112.
28. Tam PC, Siu KF, Cheung HC, et al. Local recurrences after subtotal esophagectomy for squamous cell carcinoma. Ann Surg 1987;205:189-194.
29. Holscher AH, Voit H, Buttermann G, Siewert JR. Function of the intrathoracic stomach as esophageal substitute. World J Surg 1988;12:835-844.
30. Bonavina L, Anselmino M, Ruol A, et al. Functional evaluation of the intrathoracic stomach as an oesophageal substitute. Br J Surg 1992;79:529-532.
31. Lerut T, Coosemans W, De Ley, P Van, Raemdonck D. Gastroplasty: yes or no to gastric drainage procedure. Dis Esophagus 2001;14:173-177.
32. Chattopadhyay TK, Gupta S, Padhy AK, Kapoor VK. Is pyloroplasty necessary following intrathoracic transposition of stomach? Results of a prospective clinical study. Aust N Z J Surg 1991;61:366-369.
33. Mannell A, McKnight A, Esser JD. Role of pyloroplasty in the retrosternal stomach: results of a prospective, randomized controlled trial. Br J Surg 1990;77:57-59.
34. Urschel JD, Blewett CJ, Young JE, et al. Pyloric drainage (pyloroplasty) or no drainage in gastric reconstruction after esophagectomy: a meta-analysis of randomized controlled trials. Dig Surg 2002;19:160-164.
35. Fok M, Cheng SW, Wong J. Pyloroplasty versus no drainage in gastric replacement of the esophagus. Am J Surg 1991;162:447-452.
36. Law S, Cheung MC, Fok M, et al. Pyloroplasty and pyloromyotomy in gastric replacement of the esophagus after esophagectomy: a randomized controlled trial. J Am Coll Surg 1997;184:630-636.
37. Bartels H, Thorban S, Siewert JR. Anterior versus posterior reconstruction after transhiatal oesophagectomy: a randomized controlled trial. Br J Surg 1993;80:1141-1144.
38. Ngan SYK, Wong J. Lengths of different routes for esophageal replacement. J Thorac Cardiovasc Surg 1986;91:790-792.
39. Fok M, Sham JS, Choy D, et al. Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery 1993;113:138-147.
40. Malthaner R, Fenlon D. Preoperative chemotherapy for resectable thoracic esophageal cancer (Cochrane Review). Cochrane Database Syst Rev 2001;1:CD001556-CD001556.
41. Ténière P, Hay J-M, Fingerhut A, Fagniez P-L. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. Surg Gynecol Obstet 1991;173:123-130.
42. Zieren HU, Muller JM, Jacobi CA, et al. Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: a prospective randomized study. World J Surg 1995;19:444-449.
43. Kelsen DP, Ginsberg R, Pajak TF, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998;339:1979-1984.
44. Law S, Fok M, Chow S, et al. Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg 1997;114:210-217.
45. Ando N, Iizuka T, Kakegawa T, et al. A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group Study. J Thorac Cardiovasc Surg 1997;114:205-209.
46. Pouliquen X, Levard H, Hay JM, et al. 5-Fluorouracil and cisplatin therapy after palliative surgical resection of squamous cell carcinoma of the esophagus. A multicenter randomized trial. French Associations for Surgical Research. Ann Surg 1996;223:127-133.
47. Walsh TN, Noonan N, Hollywood D, et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462-467.
48. Urschel JD, Vasan H, Blewett CJ. A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2002;183:274-279.
49. Iizuka N, Hirose K, Noma T, et al. The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma. Br J Cancer 1999;81:469-475.
50. Weber WA, Ott K, Becker K, et al. Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol 2001;19:3058-3065.
51. O'Sullivan GC, Sheehan D, Clarke A, et al. Micrometastases in esophagogastric cancer: high detection rate in resected rib segments. Gastroenterology 1999;116:543-548.
52. Bonavina L, Soligo D, Quirici N, et al. Bone marrow-disseminated tumor cells in patients with carcinoma of the esophagus or cardia. Surgery 2001;129:15-22.